Impact Factor
3.46
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.72
965 total citations
h5-index
31
h5 depth signal
Cited share
72.1%
263 of 365
Total citations
965
Citation footprint
Metric signal
2.83
External metric anchor
Self-citation
4.9%
47 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
787
China
291
Japan
175
Canada
121
Germany
118
Citing Fields of Research
Prostate Cancer
1,533
Urology
222
Cancer & Development
141
Immunology
109
Genetics & Genomics
99
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,759
Articles tracked across the journal lifetime
Indexed publication set
365
263 cited publications
Last 12 months
202
16.8 publications/month
Open access share
30.7%
62 OA publications in the last year
Leading citing country
United States
787 citing publications
Leading citing field
Prostate Cancer
1,533 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1980-
v1n1, 1980-
Active Coverage
Research Focus & Classification
Indexed Subjects
Prostate Cancer
Broad Categories
Urology
Prostate Cancer
MeSH Descriptors
Prostate
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/pros.70268
Open DOI
Age Does Not Independently Predict Biochemical Recurrence in Prostate Cancer Following Radical Prostatectomy: A Comparative Analysis of 4223 pT2N0R0 Patients
Background: Whether younger age independently predicts biochemical recurrence (BCR) after radical prostatectomy (RP) remains controversial because previous studies have included heterogeneous pathological stages and treatment populations...
02
DOI 10.1002/pros.70269
Open DOI
Real‐World HRR Testing Pathways and Patterns of Detected Alterations in Prostate Cancer From the Multinational ARON‐3 Study
Background: Homologous recombination repair (HRR) testing is increasingly relevant in prostate cancer because it identifies patients who may benefit from biomarker‐guided treatment strategies, including poly(ADP‐ribose) polymerase inhibi...
03
DOI 10.1002/pros.70257
Open DOI
Issue Information
04
DOI 10.1002/pros.70267
Open DOI
Circulating Tumor Cell Synaptophysin and Androgen Receptor Expression Reflect Prostate Cancer Phenotypes in Metastatic Disease
Background: Chronic exposure to androgen receptor (AR)‐targeted therapies can drive lineage plasticity, leading to treatment resistance and neuroendocrine prostate cancer (NEPC), characterized by loss of AR expression and acquisition of ...
05
DOI 10.1002/pros.70226
Open DOI
Exploratory Analysis of Peri‐Prostatic Adipose Tissue Radiomics Features and Their Potential to Predict Prostate Cancer Diagnosis: Results From a UK Biobank Study
Introduction: This paper reports the development and application of an artificial intelligence (AI)–led approach to large volume MRI data curation and image segmentation of periprostatic adipose tissue (PPAT) in prostate cancer (PCa)–fre...
06
07
DOI 10.1002/pros.70266
Open DOI
Evaluation of Time to Metastasis After Prostatectomy as a Prognostic Factor in Patients With Metachronous mHSPC: A Secondary Analysis of the SWOG‐1216 Phase 3 Trial
Background: The prognostic significance of time to metastasis (TTM) following radical prostatectomy in patients with metachronous metastatic hormone‐sensitive prostate cancer (mHSPC) remains uncertain. We performed a secondary analysis o...
08
DOI 10.1002/pros.70265
Open DOI
Stage‐Specific Racial Disparities in Prostate Cancer Survival Outcomes
Background: Racial disparities in prostate cancer (PCa) survival are inconsistently reported. Methods: We evaluated long‐term survival in 976 men from the NCI–Maryland PCa case‐control study, stratified by disease stage. Results: There w...
09
DOI 10.1002/pros.70248
Open DOI
Human Prostate Cell Lines: Derivation, Molecular Characteristics and Appropriate Use
Background: Research on prostate cancer and benign prostatic hyperplasia depends on a small number of immortalized human cell lines established between 1977 and 2001, most of them from advanced metastatic disease. The cell lines differ f...
10
DOI 10.1002/pros.70258
Open DOI
Urinary Soluble Collagen Levels Are Associated With Moderate/Severe LUTS
Background: Expansion of the stromal compartment of the prostate concurrent with fibroblast activation and increased collagenization is now recognized as a pathobiology likely contributing to Lower Urinary Tract Symptoms (LUTS). However,...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
(1989)19890816 Notice published Printed on acid-free paper